Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01978899 · ClinicalTrials.gov registry record · NA

Healthy Living After Cancer: Weight Management Pilot Study

A NA study, sponsored by Dana-Farber Cancer Institute.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT01978899: Completed NA study, sponsored by Dana-Farber Cancer Institute.

NCT01978899 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01978899, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

Studies have shown that patients who weigh more at the time of cancer diagnosis may be at increased risk of complications from surgery, fatigue, poor body image and other problems. Some research suggests that losing weight after cancer diagnosis can lead to improvements in these problems, as well as having other potential benefits for cancer survivors. Programs that reduce calories and increase exercise have been shown to help cancer survivors lose weight, but more research is needed to develop and test weight loss programs in cancer survivors. This study is designed to look at the ability of a 15-week diet and exercise program to help cancer survivors lose weight. The investigator will look at changes in weight, body composition, quality of life, fatigue, body image as well as diet and exercise patterns, to see if this program can help men and women feel better and live healthier lives after cancer diagnosis.

Primary Outcome

Change in weight (post-pre)weight loss intervention

Interventions

  • BEHAVIORAL Immediate Weight Loss Program Group
  • BEHAVIORAL Delayed Weight Loss Program Group

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2013-11
Est. Completion 2016-02
Phase NA
Dana-Farber Cancer Institute

781 total trials

What the finished NCT01978899 record still lists

NCT01978899 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Immediate Weight Loss Program Group is the first listed.

NCT01978899 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01978899 about?

NCT01978899 is a clinical study titled "Healthy Living After Cancer: Weight Management Pilot Study". Studies have shown that patients who weigh more at the time of cancer diagnosis may be at increased risk of complications from surgery, fatigue, poor body image and other problems. Some research suggests that losing weight after cancer diagnosis can lead to improvements in these problems, as well as...

What is the current status of trial NCT01978899?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2013-11. Estimated completion is 2016-02.

What interventions are being tested in trial NCT01978899?

The interventions under investigation include: Immediate Weight Loss Program Group (BEHAVIORAL), Delayed Weight Loss Program Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT01978899?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01978899's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01978899, the US trial registry maintained by the National Library of Medicine. NCT01978899 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.